New treatment option for Pregnant Women
Official title Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section
ClinicalTrials.gov ID: NCT06357546
What this study is testing
- What it's testing
- The hypothesis of this trial is that the absence of systematic bladder catheterization in patients performing spontaneous urination in the hour preceding the planned cesarean section under spinal anesthesia would not lead to more bladder heterocatheterization for postpartum urinary retention (RUPP) in the 24 hours post-cesarean section than systematic intraoperative bladder catheterization up to 2 hours post-surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Adult patient
- Patient admitted for a planned cesarean section after 34 weeks under spinal anesthesia
- Single or twin pregnancy
- Unscarred or with one or two scars of the uterus
You likely can't join if
- Positive urine test strip showing a presence of nitrites or leukocytes, the day before the surgery suggesting asymptomatic bacteriuria
- Emergency Caesarean
- Scheduled Caesarean section with intervention delayed beyond 3 p.m. for service organization reasons
- Epidural anesthesia
- Contraindication to spinal anesthesia (uncorrected hypovolemia; blood coagulation disorders; sepsis or severe inflammation at the puncture site...
- ASA (American Society of Anesthesiologists) score ≥ 4
See the full eligibility criteria
- Adult patient
- Patient admitted for a planned cesarean section after 34 weeks under spinal anesthesia
- Single or twin pregnancy
- Unscarred or with one or two scars of the uterus
- Positive urine test strip showing a presence of nitrites or leukocytes, the day before the surgery suggesting asymptomatic bacteriuria
- Emergency Caesarean
- Scheduled Caesarean section with intervention delayed beyond 3 p.m. for service organization reasons
- Epidural anesthesia
- Contraindication to spinal anesthesia (uncorrected hypovolemia; blood coagulation disorders; sepsis or severe inflammation at the puncture site; neurological deficit; migraine pattern; spinal cord disease; spinal...
- ASA (American Society of Anesthesiologists) score ≥ 4
- Placental insertion abnormality (placenta previa and/or accreta)
- Medical indication for monitoring of diuresis
- Oliguria or renal failure
- Indication for use of intrathecal clonidine during scheduled cesarean section
- History of bladder surgery or surgical urological pathology during pregnancy (JJ catheter in place)
- History of complex abdominal surgery
- Impossibility or absence of obtaining free, informed and written consent, after a period of reflection
- Patient not affiliated or beneficiary of a national health insurance system
- Patient under legal protection, under guardianship or under curatorship
- Patient having participated in treatment research on a drug within 3 months before inclusion
- Patient participating in another treatment research
- Patient in exclusion period determined by another study
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, France
- Nîmes, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, France; Nîmes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.